Christopher Devall Biography and Net Worth

COO of Dominari

With two decades of experience in building and leading successful, high-performing teams, Mr. Devall supports Dominari’s business units by providing operational expertise across all administrative functions. His wide-ranging career includes management positions in multiple industries including government procurement, biotech, and manufacturing. He is a retired military veteran and holds an MBA from the University of Virginia’s Darden School of Business.

What is Christopher Franklin Devall's net worth?: The estimated net worth of Christopher Franklin Devall is at least $373.00 thousand as of December 8th, 2025. Mr. Devall owns 145,702 shares of Dominari stock worth more than $372,997 as of September 22nd. This net worth estimate does not reflect any other investments that Mr. Devall may own. Learn More about Christopher Franklin Devall's net worth.
How do I contact Christopher Franklin Devall?: The corporate mailing address for Mr. Devall and other Dominari executives is 725 Fifth Avenue, 22nd Floor, New York, NY, 10022. Dominari can also be reached via phone at (212) 393-4540 and via email at [email protected]. Learn More on Christopher Franklin Devall's contact information.
Has Christopher Franklin Devall been buying or selling shares of Dominari?: Christopher Franklin Devall has not been actively trading shares of Dominari during the last ninety days. Most recently, Christopher Franklin Devall sold 45,000 shares of the business's stock in a transaction on Monday, December 8th. The shares were sold at an average price of $3.85, for a transaction totalling $173,250.00. Following the completion of the sale, the chief operating officer now directly owns 145,702 shares of the company's stock, valued at $560,952.70. Learn More on Christopher Franklin Devall's trading history.
Who are Dominari's active insiders?: Dominari's insider roster includes Christopher Devall (COO), Anthony Hayes (CEO), and Kyle Wool (President). Learn More on Dominari's active insiders.
Are insiders buying or selling shares of Dominari?: During the last year, Dominari insiders bought shares 2 times. They purchased a total of 100,000 shares worth more than $202,000.00. During the last year, insiders at the sold shares 3 times. They sold a total of 225,000 shares worth more than $876,850.00. The most recent insider tranaction occured on September, 10th when CEO Anthony Hayes bought 50,000 shares worth more than $101,000.00. Insiders at Dominari own 55.3% of the company. Learn More about insider trades at Dominari.
Information on this page was last updated on 9/10/2026.

Christopher Franklin Devall Insider Trading History at Dominari

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/8/2025	Sell	45,000	$3.85	$173,250.00	145,702
12/5/2025	Sell	140,000	$3.82	$534,800.00	190,702
12/3/2025	Sell	40,000	$4.22	$168,800.00	370,702
12/26/2023	Buy	7,000	$2.55	$17,850.00	30,033
11/28/2023	Buy	1,000	$2.26	$2,260.00	22,033
5/18/2023	Buy	1,500	$2.94	$4,410.00	21,033
4/5/2023	Buy	5,698	$3.51	$19,999.98	19,533

Christopher Franklin Devall Buying and Selling Activity at Dominari

Dominari Company Overview

Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.

Today's Range

Now: $2.56

$2.48

$2.60

50 Day Range

MA: $2.50

$1.94

$3.14

2 Week Range

Now: $2.56

$1.91

$8.40

Volume

372,049 shs

Average Volume

162,323 shs

Market Capitalization

$62.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.87